Li Yuhuan, Wang Li-xin, Pang Puiyi, Twitty Chris, Fox Bernard A, Aung Sandra, Urba Walter J, Hu Hong-Ming
Laboratory of Cancer Immunobiology, Providence Portland Medical Center, 4805 N.E. Glisan Street, Portland, OR 97213, USA.
Autophagy. 2009 May;5(4):576-7. doi: 10.4161/auto.5.4.8366. Epub 2009 May 6.
Cross-presentation of exogenous antigens by host professional antigen-presenting cells (APCs) plays a pivotal role in the initiation and development of T-cell immune responses to tumor-associated antigens, including self or mutated self-antigens derived from tumor cells, and foreign antigens derived from infectious agents. Cross-presentation requires multiple steps that involve the antigens' synthesis and compartmentalization in donor cells, packaging and delivery, and processing and presentation by MHC class I molecules on professional APCs. The intricate pathways that lead to protein degradation and the formation of MHC I-peptide complexes inside the APC are well documented for both soluble and particulate antigens. However, much less is known about how cross-presentation is regulated by the protein degradation pathways in antigen-donor cells (ADCs), including autophagy-mediated lysosomal proteolysis and proteasomal degradation. The exact nature or form of the antigens derived from donor cells at the time of delivery to the APC for cross-presentation is very controversial.
宿主专职抗原呈递细胞(APC)对外源抗原的交叉呈递在针对肿瘤相关抗原的T细胞免疫反应的启动和发展中起着关键作用,这些抗原包括源自肿瘤细胞的自身或突变自身抗原,以及源自感染因子的外来抗原。交叉呈递需要多个步骤,包括抗原在供体细胞中的合成和区室化、包装和递送,以及在专职APC上由MHC I类分子进行加工和呈递。对于可溶性和颗粒性抗原,导致APC内蛋白质降解和MHC I-肽复合物形成的复杂途径已有充分记录。然而,关于抗原供体细胞(ADC)中的蛋白质降解途径如何调节交叉呈递,包括自噬介导的溶酶体蛋白水解和蛋白酶体降解,人们了解得要少得多。在递送至APC进行交叉呈递时,源自供体细胞的抗原的确切性质或形式极具争议。